Janssen’s Brian Woodfall discusses the pharmaceutical company’s research process for their monthly injectable HIV treatment and their predictions for the future of the condition.
Click on the pic for more details.
HIV can be a debilitating and life-altering disease; with the potential to be fatal, it is vital that pharmaceutical companies develop treatments to combat the condition.
European Pharmaceutical Review’s Victoria Rees spoke with Brian Woodfall, VP, Global Head Development, Infectious Diseases at Janssen Research & Development, who has studied HIV and investigated potential treatments throughout his career. He explained the intricacies of the disease and the complications of finding a cure.
